Medical Microbiology and Immunology

, Volume 193, Issue 2–3, pp 109–114 | Cite as

Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes

  • Hongyi ZhangEmail author
  • Yanwen Li
  • Dougal R. McClean
  • Peter J. Richardson
  • Richard Florio
  • Mary Sheppard
  • Karen Morrison
  • Najma Latif
  • Michael J. Dunn
  • Leonard C. Archard
Original Investigation


The association of enteroviruses with myocardial disease has been investigated extensively by molecular biological techniques to detect viral RNA, but remains controversial. This retrospective study investigated the involvement of enterovirus in myocarditis or dilated cardiomyopathy (DCM) by detection of viral antigens in myocardial samples from a new patient series using an optimized immunohistochemical technique. Formalin-fixed, paraffin-embedded biopsy, autopsy or explanted myocardial tissue samples were obtained from 136 subjects. These comprised histologically proven cases of acute fatal myocarditis (n=10), DCM (n=89, including 10 patients with healing/borderline myocarditis) and a comparison group of samples from 37 unused donor hearts and cases with other conditions. A monoclonal antibody 5-D8/1 directed against a conserved, non-conformational epitope in capsid protein VP1 was employed for broad detection of different enterovirus serotypes. Investigations were performed blindly. Histological sections from 7 of 10 fatal myocarditis cases, 47 of 89 patients (52.8%) with DCM were positive for the viral capsid protein VP1 by immunohistochemical staining. Consecutive sections of positive samples were negative when the antibody was omitted or replaced with subclass- and concentration-matched normal mouse IgG. In contrast, only 3 of 37 samples (8.1%) in the comparison group were positive (Yates corrected χ2=19.99, P<0.001: odds ratio =12.68). VP1 staining was distributed in individual or grouped myofibers and localized in the cytoplasm of myocytes. In some cases, VP1 was detected in only a few myofibers within an entire section. These results provide further evidence of enterovirus involvement in a high proportion of DCM cases and demonstrate that VP1 is present in disease stages from acute myocarditis, healing myocarditis to end-stage DCM requiring cardiac transplantation, indicating translation of viral protein during persistent enterovirus infection.


Enterovirus Antigen Myocarditis Dilated cardiomyopathy Immunohistochemistry 



This work was supported by the British Heart Foundation.


  1. 1.
    Andreoletti L, Bourlet T, Moukassa D, Rey L, Hot D, Li Y, Lambert V, Gosselin B, Mosnier JF, Stankowiak C, Wattre PJ (2000) Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy. Infect Dis 182:1222–1227CrossRefGoogle Scholar
  2. 2.
    Archard LC, Khan MA, Soteriou DA, Zhang HY, Why HJF, Robinson NM, Richardson PJ (1998) Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 29:578–584Google Scholar
  3. 3.
    Aretz HT (1986) Myocarditis: the Dallas criteria. Hum Pathol 18:619–624Google Scholar
  4. 4.
    Arola A, Kallajoki M, Ruuskanen O, Hyypia T (1998) Detection of enteroviral RNA in end-stage dilated cardiomyopathy in children and adolescents. J Med Virol 56:364–371CrossRefPubMedGoogle Scholar
  5. 5.
    Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320–326PubMedGoogle Scholar
  6. 6.
    Crespo-Leiro MG, Hermida-Prieto M, Pena F, Portela F, Muniz J, Hermida LF, Juffe-Stein A, Castro-Beiras A (2000) Absence of enteroviral RNA in hearts explanted from patients with dilated cardiomyopathy. J Heart Lung Transplant 19:134–138CrossRefPubMedGoogle Scholar
  7. 7.
    Deguchi H, Fujioka S, Terasaki F, Ukimura A, Hirasawa M, Kintaka T, Kitaura Y, Kondo K, Sasaki S, Isomura T, Suma H (2001) Enterovirus RNA replication in cases of dilated cardiomyopathy: light microscopic in situ hybridization and virological analyses of myocardial specimens obtained at partial left ventriculectomy. J Card Surg 16:64–71PubMedGoogle Scholar
  8. 8.
    Foulis AK, Farquharson MA, Cameron SO, McGill M, Schonke H, Kandolf R (1990) A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with Type 1 diabetes and pancreases and heart of infants who died of coxsackieviral myocarditis. Diabetologia 33:290–298PubMedGoogle Scholar
  9. 9.
    Henke A, Wagner E, Whitton JL, Zell R, Stelzner A (1998) Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization. J Virol 72:8327–8331PubMedGoogle Scholar
  10. 10.
    Huber M, Watson KA, Selinka HC, Carthy CM, Klingel K, McManus BM, Kandolf R (1999) Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol 73:3587–3594PubMedGoogle Scholar
  11. 11.
    Kandolf R, Ameis D, Krischner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic and hybridisation—an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 84:6272–6276PubMedGoogle Scholar
  12. 12.
    Klingel K, Rieger P, Mall G, Selinka HC, Huber M, Kandolf R (1998) Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Lab Invest 78:1227–1237PubMedGoogle Scholar
  13. 13.
    Li Y, Bourlet T, Andreoletti L, Mosnier J-F, Peng T, Yang Y, Archard LC, Pozzetto B, Zhang H (2000) Enteroviral capsid protein VP1 is present in myocardial tissues from patients with myocarditis and dilated cardiomyopathy. Circulation 101:231–234PubMedGoogle Scholar
  14. 14.
    Li Y, Peng T, Yang Y, Niu C, Archard LC, Zhang H (2000) High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart 83:696–701Google Scholar
  15. 15.
    Liljeqvist JA, Bergstrom A, Holmstrom S, Samuelson A, Yousef GE, Waagstein F, Jeansson S (1993) Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy. J Med Virol 39:6–10PubMedGoogle Scholar
  16. 16.
    Lotze U, Busch HJ, Aschoff A, Gluck B, Sigusch H, Jirikowski G, Stelzner A, Figull HR (2001) Damaged myocytes as detected by the colocalization of DNA fragmentation and tissue transglutaminase and their prognostic significance in enterovirus-associated dilated cardiomyopathy. Eur J Clin Invest 31:744–755CrossRefPubMedGoogle Scholar
  17. 17.
    Martino TA, Liu P, Sole MJ (1994) Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74:182–188PubMedGoogle Scholar
  18. 18.
    Melnick JL (1995) Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Field BN, Knipe DM, Howley MP (eds) Virology, 3rd edn. Raven Press, New York, pp 655–712Google Scholar
  19. 19.
    Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossmann MG (1995) The structure of coxsackievirus B3 at 3.5 Å resolution. Structure 3:653–667PubMedGoogle Scholar
  20. 20.
    Muir P (1993) Enterovirus and heart disease. Br J Biomed Sci 50:258–271PubMedGoogle Scholar
  21. 21.
    Muir P, Banatvala JE (1990) Reactivity of enterovirus-specific IgM with infective and defective coxsackie B virions in patients with monotypic and multitypic IgM responses. J Virol Methods 29:209–224CrossRefPubMedGoogle Scholar
  22. 22.
    Muir P, Nicholson F, Tilzey AJ, Siagny M, English TA, Banatvala JE (1989) Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet I:804–807CrossRefGoogle Scholar
  23. 23.
    Olsen EGJ (1985) Histologic aspects of viral myocarditis and its diagnostic criteria. In: Sekiguchi M, Olsen EJG, Goodwin JF (eds) Myocarditis and related disorders. Springer, Berlin Heidelberg New York, pp 130–132Google Scholar
  24. 24.
    Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, Schultheiss HP (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889–895PubMedGoogle Scholar
  25. 25.
    Romero JR (2001) Pleconaril: a novel antipicornaviral drug. Expert Opin Investig Drugs 10:369–379PubMedGoogle Scholar
  26. 26.
    Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, Pileri SA (1998) The EnVision system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51:506–511PubMedGoogle Scholar
  27. 27.
    Samuelson A, Forsgren M, Sällberg M (1995) Chartacterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody. Clin Diagn Lab Immunol 2:385–386PubMedGoogle Scholar
  28. 28.
    Strikas RA, Anderson LJ, Parker RA (1986) Temperal and geographic patterns of isolates of nonpolio enterovirus in the United States,1970–1983. J Infect Dis 153:346–351PubMedGoogle Scholar
  29. 29.
    Toniolo A, Falcone V, Bernasconi C, Basolo F, Speziale P, Onodera T (2002) DNA immunization of mice against the VP1 capsid protein of coxsackievirus B4. Scand J Immunol 56:448–455CrossRefPubMedGoogle Scholar
  30. 30.
    Trabelsi A, Grattard F, Nejmeddine M, Aouni M, Bourlet T, Pozzetto B (1995) Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5-D8/1, in comparison with neutralization and PCR for rapid identification of enterovirus in cell culture. J Clin Microbiol 33:2454–2457PubMedGoogle Scholar
  31. 31.
    Why HJF, Meany BT, Richardson PJ, Olsen EGJ, Bowles NE, Cunningham L, Freeke CA, Archard LC (1994) Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89:2582–2589PubMedGoogle Scholar
  32. 32.
    Woodruff JF (1980) Viral myocarditis: a review. Am J Pathol 101:427–479Google Scholar
  33. 33.
    Yousef GE, Brown IN, Mowbray JF (1987) Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Interovirology 28:163–170Google Scholar
  34. 34.
    Zhang H, Li Y, Peng T, Aasa M, Zhang L, Yang Y, Archard LC (2000) Localization of enteroviral antigen in myocardium and other tissues from patients with heart muscle disease by an improved immunohistochemical technique. J Histochem Cytochem 48:579–584PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Hongyi Zhang
    • 1
    • 5
    Email author
  • Yanwen Li
    • 1
  • Dougal R. McClean
    • 2
  • Peter J. Richardson
    • 2
  • Richard Florio
    • 3
  • Mary Sheppard
    • 3
  • Karen Morrison
    • 4
  • Najma Latif
    • 4
  • Michael J. Dunn
    • 4
  • Leonard C. Archard
    • 1
  1. 1.Cell and Molecular Biology Section, Division of Biomedical Sciences, Faculty of MedicineImperial CollegeLondonUK
  2. 2.Cardiac DepartmentKing’s College HospitalLondonUK
  3. 3.Department of Histopathology, Royal Brompton HospitalImperial CollegeLondonUK
  4. 4.Heart Science Centre, Harefield Hospital, Imperial CollegeHarefieldUK
  5. 5.Clinical Microbiology and Public Health Laboratory, Health Protection Agency Level 6 Box 236Addenbrooke’s HospitalCambridgeUK

Personalised recommendations